img

Global Chronic Gastritis Treatment Market Size By Available Treatments, By End-Users, By Technology, By Geographic Scope And Forecast


Published on: 2024-08-08 | No of Pages : 320 | Industry : latest updates trending Report

Publisher : MIR | Format : PDF&Excel

Global Chronic Gastritis Treatment Market Size By Available Treatments, By End-Users, By Technology, By Geographic Scope And Forecast

Chronic Gastritis Treatment Market Size and Forecast

Chronic Gastritis Treatment Market size was valued at USD 9.2 Billion in 2023 and is projected to reach USD 17.3 Billion by 2030, growing at a CAGR of 5.2% during the forecasted period from 2024 to 2030.

Global Chronic Gastritis Treatment Market Drivers

The growth and development of the Chronic Gastritis Treatment Market drivers. These factors have a big impact on how Chronic Gastritis Treatment are demanded and adopted in different sectors. Several of the major market forces are as follows

  • Growing Prevalence of Chronic Gastritis The need for efficient therapies is fueled by the increasing incidence and prevalence of chronic gastritis. Dietary practices, rising stress levels, and lifestyle factors are some of the causes of the rising number of gastritis patients.
  • Developments in Diagnostic Technologies Early and more precise diagnosis of chronic gastritis can result from advances in diagnostic procedures like endoscopy and imaging. This could therefore fuel the need for available treatment choices.
  • Drug Development and Innovation Continuous research and development initiatives to bring new medications and treatment modalities for the treatment of chronic gastritis can propel market expansion. Novel approaches to drug composition, like less side effect-prone tailored medicines, might become popular.
  • Increasing Geriatric Population The aging population is more prone to chronic health issues, including gastritis. Treatments for chronic gastritis are expected to become more in demand as the world’s population ages.
  • Knowledge and Education Initiatives Increasing patient visits and treatment-seeking behavior may be a result of initiatives that promote early detection and management of chronic gastritis and raise public knowledge of digestive health.
  • Government Measures and Healthcare Policies The market for chronic gastritis treatments may be positively impacted by measures to enhance the general healthcare infrastructure, healthcare reimbursement programs, and supportive government policies.
  • Modifying Lifestyles and Dietary Patterns Unhealthy lifestyles, such as erratic eating patterns and a rise in the intake of processed or spicy foods, can hasten the onset of gastritis. Dietary modifications may have an impact on the need for therapies.
  • Partnerships and Collaborations Partnerships and collaborations among pharmaceutical corporations, academic institutions, and healthcare organizations may encourage the creation of novel treatment options, which would propel market expansion.
  • Global Economic variables The use of chronic gastritis therapies may be influenced by economic variables such as growing disposable income and rising healthcare costs.
  • Patient Preference for Non-Invasive Treatments The market may be influenced by patients’ increasing inclination for less invasive or non-invasive treatment options, such as prescription drugs rather than surgery.

Global Chronic Gastritis Treatment Market Restraints

The Global Chronic Gastritis Treatment Market has a lot of room to grow, but there are several industry limitations that could make it harder for it to do so. It’s imperative that industry stakeholders comprehend these difficulties. Among the significant market limitations are

  • Restricted Therapy Options One of the challenges associated with chronic gastritis may be its limited therapy options or lack of a conclusive cure. This can effect the happiness of both healthcare providers and patients.
  • Medication Side Effects Certain drugs used to treat chronic gastritis may cause adverse effects. Treatment choices and patient compliance may be impacted by worries about negative drug responses or intolerance.
  • High Treatment Cost Especially in areas with tight healthcare budgets or where patients may be facing financial hardships, the expense of prescription drugs, diagnostic tests, and treatment interventions can be a major barrier.
  • Tough Regulatory Approval Procedures The introduction of novel medicines to the market may be delayed as a result of the rigorous regulatory approval procedures for new drugs. This could impede the rate of progress in the management of chronic gastritis.
  • Lack of Knowledge and Delayed Diagnosis Inadequate knowledge about the signs and symptoms of chronic gastritis might result in a delayed diagnosis and treatment start. This may worsen the condition and have an effect on patient outcomes.
  • Generic Competition The income of pharmaceutical businesses may be impacted by increasing competition and pricing pressure for branded pharmaceuticals as a result of patent expirations and the introduction of generic equivalents into the market.
  • Alternative Therapies In place of traditional medical care, some people choose complementary or alternative therapies, such as herbal remedies or lifestyle changes. The need for pharmacological therapies may be impacted by this.
  • Complexity of Illness Management Coordinated care and treatment techniques may be necessary, adding to the obstacles. Chronic gastritis may be associated with various underlying health issues, making illness management more complex.
  • Antibiotic Resistance Chronic gastritis is frequently caused by Helicobacter pylori infection, and antibiotic resistance is a growing issue. This may make treatment plans more difficult to follow and less effective for some antibiotic treatments.
  • Global Economic Factors Uncertainties or economic downturns may have an influence on healthcare spending, which may limit certain patients’ access to therapies. This is especially important in areas when the economy is struggling.

Global Chronic Gastritis Treatment Market Segmentation Analysis

The Global Chronic Gastritis Treatment Market is segmented on the basis of Available Treatments, End-Users, Technology, And Geography.

Chronic Gastritis Treatment Market, By Available Treatments

  • Medication PPIs (drugs that lessen the production of stomach acid)
  • Alterations to Lifestyle and Diet Dietary adjustments include avoiding alcohol, hot foods, and some medications.
  • Surgery To treat issues or remove damaged stomach lining, surgery may be advised in extreme circumstances.

Chronic Gastritis Treatment Market, By End-Users

  • Clinics and Hospitals Principal medical facilities for diagnostic and first care.
  • Ambulatory Surgical Centers These are establishments that offer surgical procedures as outpatient procedures, such as endoscopic treatments for persistent gastritis.

Chronic Gastritis Treatment Market, By Technology

  • Endoscopy Endoscopic procedures are used for diagnosis and therapeutic interventions.
  • Pharmaceutical Interventions Market trends and product development pertaining to chronic gastritis medicines.
  • New Technologies Market effect and adoption of innovative technologies for the detection and management of persistent gastritis.

Chronic Gastritis Treatment Market, By Geography

  • North America Market dynamics affected by healthcare infrastructure, technological improvements, and prevalence of chronic gastritis.
  • Europe Varied treatment approaches and healthcare policies impacting the market.
  • Asia-Pacific The market is impacted by rising healthcare costs, growing awareness, and the occurrence of Helicobacter pylori infections.
  • Latin America Predominance of risk variables impacting market trends, accessibility to healthcare, and economic considerations
  • Middle East and Africa Unique problems relating to healthcare infrastructure and incidence of chronic gastritis.

Key Players

The major players in the Chronic Gastritis Treatment Market are

  • AstraZeneca (Nexium)
  • Pfizer (Protonix)
  • Novartis (Prevacid)
  • Takeda Pharmaceutical Company Limited (Dexilant)
  • Abbott Laboratories (Omeprazole)
  • Cipla (Pantoprazole)
  • Sun Pharmaceutical Industries Ltd. (Lansoprazole)
  • Lupin Ltd. (Esomeprazole)

Report Scope

REPORT ATTRIBUTESDETAILS
STUDY PERIOD

2020-2030

BASE YEAR

2023

FORECAST PERIOD

2024-2030

HISTORICAL PERIOD

2020-2022

UNIT

Value (USD Billion)

KEY COMPANIES PROFILED

AstraZeneca (Nexium), Pfizer (Protonix), Novartis (Prevacid), Takeda Pharmaceutical Company Limited (Dexilant), Abbott Laboratories (Omeprazole).

SEGMENTS COVERED

By Available Treatments, By End-Users, By Technology, By Geography

CUSTOMIZATION SCOPE

Free report customization (equivalent to up to 4 analyst working days) with purchase. Addition or alteration to country, regional & segment scope

Top Trending Reports

Research Methodology of Market Research

To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our .

Reasons to Purchase this Report

• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors• Provision of market value (USD Billion) data for each segment and sub-segment• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players• The current as well as the future market outlook of the industry with respect to recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions• Includes in-depth analysis of the market of various perspectives through Porter’s five forces analysis• Provides insight into the market through Value Chain• Market dynamics scenario, along with growth opportunities of the market in the years to come• 6-month post-sales analyst support

Customization of the Report

• In case of any please connect with our sales team, who will ensure that your requirements are met.

Table of Content

To get a detailed Table of content/ Table of Figures/ Methodology Please contact our sales person at ( chris@marketinsightsresearch.com )
To get a detailed Table of content/ Table of Figures/ Methodology Please contact our sales person at ( chris@marketinsightsresearch.com )